Biofil Chemicals & Pharmaceuticals Limited Cash Flow Conversion Efficiency

Latest as of September 2025: -0.167x

Biofil Chemicals & Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) has a cash flow conversion efficiency ratio of -0.167x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-35.65 Million ≈ $-385.57K USD) by net assets (Rs213.04 Million ≈ $2.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Biofil Chemicals & Pharmaceuticals Limited (2008–2025)

Cash flow conversion efficiency of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025. This chart illustrates how Biofil Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Biofil Chemicals & Pharmaceuticals Limit share price for real-time trading data and today's change.

Biofil Chemicals & Pharmaceuticals Limited Cash Flow Conversion Ratio Explained

Biofil Chemicals & Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Biofil Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biofil Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see BIOFILCHEM market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Dangee Dums Limited NSE:DANGEE	0.140x
Willow Biosciences Inc TO:WLLW	0.055x
Athena Resources Ltd AU:AHN	-0.044x
YGL Convergence Bhd KLSE:0086	0.001x
Modern Times Group Mtg AB ST:MTG-A	0.079x
HIGH QUALITY FOOD F:L24	N/A
Tenon Medical Inc NASDAQ:TNON	1.582x
Better Choice Company Inc NYSE MKT:BTTR	0.048x

Annual Cash Flow Conversion Efficiency for Biofil Chemicals & Pharmaceuticals Limited (2008–2025)

The table below shows the annual cash flow conversion efficiency of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025. Review Biofil Chemicals & Pharmaceuticals Limit free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs187.82 Million ≈ $2.03 Million	Rs-19.24 Million ≈ $-208.03K	-0.102x	-177.88%
2024-03-31	Rs182.03 Million ≈ $1.97 Million	Rs23.94 Million ≈ $258.87K	0.132x	+2135.04%
2023-03-31	Rs173.01 Million ≈ $1.87 Million	Rs-1.12 Million ≈ $-12.09K	-0.006x	+50.52%
2022-03-31	Rs168.38 Million ≈ $1.82 Million	Rs-2.20 Million ≈ $-23.78K	-0.013x	-118.96%
2021-03-31	Rs161.29 Million ≈ $1.74 Million	Rs11.11 Million ≈ $120.14K	0.069x	+14.64%
2020-03-31	Rs148.83 Million ≈ $1.61 Million	Rs8.94 Million ≈ $96.70K	0.060x	-34.69%
2019-03-31	Rs136.50 Million ≈ $1.48 Million	Rs12.56 Million ≈ $135.80K	0.092x	+161.29%
2018-03-31	Rs131.67 Million ≈ $1.42 Million	Rs4.64 Million ≈ $50.14K	0.035x	-37.16%
2017-03-31	Rs126.96 Million ≈ $1.37 Million	Rs7.11 Million ≈ $76.94K	0.056x	+347.18%
2016-03-31	Rs109.07 Million ≈ $1.18 Million	Rs1.37 Million ≈ $14.78K	0.013x	+1051.90%
2015-03-31	Rs84.15 Million ≈ $910.03K	Rs91.53K ≈ $989.89	0.001x	-95.95%
2014-03-31	Rs78.63 Million ≈ $850.35K	Rs2.11 Million ≈ $22.84K	0.027x	+253.87%
2013-03-31	Rs73.62 Million ≈ $796.22K	Rs-1.29 Million ≈ $-13.90K	-0.017x	+37.76%
2012-03-31	Rs68.36 Million ≈ $739.31K	Rs-1.92 Million ≈ $-20.73K	-0.028x	+84.95%
2011-03-31	Rs67.02 Million ≈ $724.79K	Rs-12.49 Million ≈ $-135.03K	-0.186x	-111.61%
2010-03-31	Rs17.27 Million ≈ $186.81K	Rs27.73 Million ≈ $299.89K	1.605x	+993.82%
2009-03-31	Rs11.99 Million ≈ $129.64K	Rs-2.15 Million ≈ $-23.28K	-0.180x	-173.13%
2008-03-31	Rs14.78 Million ≈ $159.86K	Rs3.63 Million ≈ $39.26K	0.246x	--

About Biofil Chemicals & Pharmaceuticals Limited

NSE:BIOFILCHEM India Drug Manufacturers - Specialty & Generic

Market Cap

$5.14 Million

Rs475.68 Million INR

Market Cap Rank

#28444 Global

#1583 in India

Share Price

Rs29.23

Change (1 day)

+0.76%

52-Week Range

Rs25.79 - Rs46.34

All Time High

Rs339.15